Home

soil Permission damage fauc mic chef Run Lover

Assessing Clinical Potential of Old Antibiotics against Severe Infections  by Multi-Drug-Resistant Gram-Negative Bacteria Using I
Assessing Clinical Potential of Old Antibiotics against Severe Infections by Multi-Drug-Resistant Gram-Negative Bacteria Using I

Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move  Forward. - Abstract - Europe PMC
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward. - Abstract - Europe PMC

A translational pharmacokinetic/pharmacodynamic model to characterize  bacterial kill in the presence of imipenem-relebactam
A translational pharmacokinetic/pharmacodynamic model to characterize bacterial kill in the presence of imipenem-relebactam

Revision of fluoroquinolone breakpoints used for interpretation of  antimicrobial susceptibility testing of canine bacterial iso
Revision of fluoroquinolone breakpoints used for interpretation of antimicrobial susceptibility testing of canine bacterial iso

SciELO - Brasil - Antifungal pharmacodynamics: Latin America's perspective  Antifungal pharmacodynamics: Latin America's perspective
SciELO - Brasil - Antifungal pharmacodynamics: Latin America's perspective Antifungal pharmacodynamics: Latin America's perspective

PPT - What is a MIC ? Relationship between a MIC and conventional  pharmacodynamic parameters PowerPoint Presentation - ID:688866
PPT - What is a MIC ? Relationship between a MIC and conventional pharmacodynamic parameters PowerPoint Presentation - ID:688866

Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A  Systematic Review and Meta-Regression of Bacterial Killing in Preclinical  Infection Models | Clinical Pharmacokinetics
Prolonged Versus Intermittent Infusion of β-Lactam Antibiotics: A Systematic Review and Meta-Regression of Bacterial Killing in Preclinical Infection Models | Clinical Pharmacokinetics

RESULTS INTRODUCTION CONCLUSIONS METHODS REFERENCES
RESULTS INTRODUCTION CONCLUSIONS METHODS REFERENCES

No Slide Title
No Slide Title

Mechanism-based PKPD-models for Selection of Dosing Regimens for Antibiotics
Mechanism-based PKPD-models for Selection of Dosing Regimens for Antibiotics

Relationship between MIC and fAUC and proportion of patients with... |  Download Scientific Diagram
Relationship between MIC and fAUC and proportion of patients with... | Download Scientific Diagram

Erin McCreary on X: "@jpogue1 starts overview of polymyxins international  consensus guideline with discussion on target to achieve 1 log kill. In  murine thigh infection model, free AUC/MIC target ~12, total target ~
Erin McCreary on X: "@jpogue1 starts overview of polymyxins international consensus guideline with discussion on target to achieve 1 log kill. In murine thigh infection model, free AUC/MIC target ~12, total target ~

Pharmacokinetic and pharmacodynamic profiling of minocycline for injection  following a single infusion in critically ill adults
Pharmacokinetic and pharmacodynamic profiling of minocycline for injection following a single infusion in critically ill adults

Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move  Forward
Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward

In Vivo Efficacy and PK/PD Modeling of KBP-7072, An Aminomethylcycline  Antibiotic, in Neutropenic Pneumonia and Thigh Infection Models | bioRxiv
In Vivo Efficacy and PK/PD Modeling of KBP-7072, An Aminomethylcycline Antibiotic, in Neutropenic Pneumonia and Thigh Infection Models | bioRxiv

Frontiers | Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back  to Move Forward
Frontiers | Limitations of Antibiotic MIC-Based PK-PD Metrics: Looking Back to Move Forward

RESULTS INTRODUCTION CONCLUSIONS METHODS REFERENCES
RESULTS INTRODUCTION CONCLUSIONS METHODS REFERENCES

Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis  during Acute Pulmonary Exacerbation | Antimicrobial Agents and Chemotherapy
Pharmacokinetics of Telavancin in Adult Patients with Cystic Fibrosis during Acute Pulmonary Exacerbation | Antimicrobial Agents and Chemotherapy

Population pharmacokinetics of enrofloxacin and florfenicol in the giant  danio (Devario aequipinnatus) following oral administration of both  antibiotics and bath administration of enrofloxacin - ScienceDirect
Population pharmacokinetics of enrofloxacin and florfenicol in the giant danio (Devario aequipinnatus) following oral administration of both antibiotics and bath administration of enrofloxacin - ScienceDirect

What Every Steward Should Know About Pharmacokinetics and Pharmacodynamics  (Chapter 8) - Practical Implementation of an Antibiotic Stewardship Program
What Every Steward Should Know About Pharmacokinetics and Pharmacodynamics (Chapter 8) - Practical Implementation of an Antibiotic Stewardship Program

Recent Updates on the Role of Pharmacokinetics- pharmacodynamics in  Antimicrobial Susceptibility Testing as Applied to Clinical
Recent Updates on the Role of Pharmacokinetics- pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical

fAUC/MIC values of subcutaneous colistin and polymyxin B at 30 mg/kg/8 h |  Download Scientific Diagram
fAUC/MIC values of subcutaneous colistin and polymyxin B at 30 mg/kg/8 h | Download Scientific Diagram

PDF] fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index  of colistin against Acinetobacter baumannii in murine thigh and lung  infection models. | Semantic Scholar
PDF] fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models. | Semantic Scholar

Evaluating a tylosin dosage regimen for treatment of Staphylococcus  delphini infection in mink (Neovison vison): a  pharmacokinetic-pharmacodynamic approach | Veterinary Research | Full Text
Evaluating a tylosin dosage regimen for treatment of Staphylococcus delphini infection in mink (Neovison vison): a pharmacokinetic-pharmacodynamic approach | Veterinary Research | Full Text

Full article: Pharmacokinetics, pharmacodynamics and efficacy of novel FabI  inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model
Full article: Pharmacokinetics, pharmacodynamics and efficacy of novel FabI inhibitor AFN-1252 against MSSA and MRSA in the murine thigh infection model